Coldstream Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
16,912
-811
| -5% | -$56.7K | 0.02% | 382 |
|
|
2025
Q1 | $1.3M | Sell |
17,723
-7,083
| -29% | -$521K | 0.03% | 330 |
|
|
2024
Q4 | $1.63M | Sell |
24,806
-1,971
| -7% | -$129K | 0.03% | 284 |
|
|
2024
Q3 | $2.09M | Buy |
26,777
+1,050
| +4% | +$81.8K | 0.05% | 230 |
|
|
2024
Q2 | $2.01M | Buy |
25,727
+11,102
| +76% | +$866K | 0.05% | 202 |
|
|
2024
Q1 | $991K | Buy |
14,625
+3,279
| +29% | +$222K | 0.03% | 325 |
|
|
2023
Q4 | $764K | Buy |
11,346
+2,513
| +28% | +$169K | 0.02% | 360 |
|
|
2023
Q3 | $598K | Buy |
8,833
+856
| +11% | +$58K | 0.02% | 366 |
|
|
2023
Q2 | $571K | Buy |
7,977
+17
| +0.2% | +$1.22K | 0.02% | 400 |
|
|
2023
Q1 | $553K | Buy |
7,960
+67
| +0.8% | +$4.65K | 0.02% | 402 |
|
|
2022
Q4 | $535K | Buy |
+7,893
| New | +$535K | 0.02% | 407 |
|
|
2022
Q2 | $364K | Buy |
5,507
+1,505
| +38% | +$99.5K | 0.01% | 499 |
|
|
2022
Q1 | $265K | Sell |
4,002
-1,649
| -29% | -$109K | 0.01% | 622 |
|
|
2021
Q4 | $329K | Buy |
+5,651
| New | +$329K | 0.01% | 575 |
|